DNMT3A and myeloproliferative neoplasm: DNMT3A mutations are frameshift/nonsense, resulting in reduced methyltransferase activity, and occur in 5–15% of MPN patients, with lower frequency in PV and ET compared to PMF and BP [48,49,50].